These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33298644)

  • 1. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3.
    Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Yamaji K; Watanabe H; Shizuta S; Kato T; Ando K; Nakagawa Y; Furukawa Y; Tada T; Nagao K; Kadota K; Toyofuku M; Kimura T
    Circ Cardiovasc Interv; 2019 Nov; 12(11):e008307. PubMed ID: 31707804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction.
    Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    J Atheroscler Thromb; 2023 Mar; 30(3):299-309. PubMed ID: 35613875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction.
    Sotomi Y; Hikoso S; Nakatani D; Suna S; Dohi T; Mizuno H; Okada K; Kida H; Oeun B; Sunaga A; Sato T; Kitamura T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y;
    Heart Vessels; 2021 Oct; 36(10):1484-1495. PubMed ID: 33743047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Roongsangmanoon W; Wongsoasup A; Chichareon P; Suwannasom P; Chandavimol M; Limpijankit T; Srimahachota S; Hutayanon P; Kiatchoosakun S; Siriwiwattnakul N; Promlikitchai P; Siriyotha S; Thakkinstian A; Sansanayudh N
    Int J Cardiol; 2023 Oct; 388():131167. PubMed ID: 37429447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transradial vs. Transfemoral Percutaneous Coronary Intervention in Patients With or Without High Bleeding Risk Criteria.
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Watanabe H; Yamaji K; Watanabe H; Kato T; Saito N; Ando K; Kadota K; Furukawa Y; Kimura T;
    Circ J; 2020 Apr; 84(5):723-732. PubMed ID: 32188831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry.
    Nakamura M; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Iijima R; Harada A; Kuroda T; Murakami Y
    EuroIntervention; 2021 Feb; 16(14):1154-1162. PubMed ID: 32624464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
    Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
    EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic ability of Japanese version of high bleeding risk criteria for ischemic outcomes in patients with acute myocardial infarction.
    Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    Heart Vessels; 2024 Jan; 39(1):1-9. PubMed ID: 37598361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent.
    Okabe K; Miura K; Shima Y; Ikuta A; Taguchi Y; Takahashi K; Osakada K; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2022 Aug; 86(9):1379-1387. PubMed ID: 35400715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention.
    Abu-Assi E; Raposeiras-Roubín S; Cespón Fernández M; Caneiro Queija B; Melendo Viu M; Íñiguez Romo A
    Rev Esp Cardiol (Engl Ed); 2022 May; 75(5):375-383. PubMed ID: 33865751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria and clinical outcomes in patients with acute coronary syndrome.
    Shimono H; Tokushige A; Kanda D; Ohno A; Hayashi M; Fukuyado M; Akao M; Kawasoe M; Arikawa R; Otsuji H; Chaen H; Okui H; Oketani N; Ohishi M
    J Cardiol; 2023 Jun; 81(6):553-563. PubMed ID: 36682715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of original and modified Academic Research Consortium for High Bleeding Risk definitions in real-world practice.
    Takahashi K; Miura K; Shima Y; Okabe K; Ikuta A; Taguchi Y; Ohya M; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    J Cardiol; 2022 Aug; 80(2):155-161. PubMed ID: 35282943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Watanabe H; Yamamoto K; Imada K; Domei T; Yamaji K; Kaneda K; Taniguchi R; Ehara N; Nawada R; Toyofuku M; Shinoda E; Suwa S; Tamura T; Inada T; Matsuda M; Aoyama T; Sato Y; Furukawa Y; Ando K; Nakagawa Y; Kimura T;
    Circ J; 2021 Oct; 85(11):1928-1941. PubMed ID: 33907052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients.
    Silverio A; Di Maio M; Buccheri S; De Luca G; Esposito L; Sarno G; Vecchione C; Galasso G
    Int J Cardiol; 2022 Jan; 347():8-15. PubMed ID: 34774882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications and characteristics of high bleeding risk in East Asian patients undergoing percutaneous coronary intervention: Start with what is right rather than what is acceptable.
    Nakamura M; Iijima R
    J Cardiol; 2021 Aug; 78(2):91-98. PubMed ID: 33358236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention.
    Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Yamamoto E; Soejima H; Matsushita K; Tsujita K
    Cardiovasc Interv Ther; 2023 Jul; 38(3):299-308. PubMed ID: 36877333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of Academic Research Consortium for High Bleeding-Risk scores on clinical outcomes in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
    Shimono H; Tokushige A; Kanda D; Ohno A; Arikawa R; Chaen H; Okui H; Oketani N; Ohishi M
    Heart Vessels; 2024 Dec; 39(12):995-1008. PubMed ID: 38842586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial.
    Popolo Rubbio A; Testa L; Pivato CA; Regazzoli D; Piccolo R; Esposito G; Musto C; Scalia L; Pacchioni A; Briguori C; Lucisano L; De Luca L; Conrotto F; Tartaglia F; Latini AC; Stankowski K; Chiarito M; Sardella G; Indolfi C; Bedogni F; Reimers B; Condorelli G; Stefanini GG
    Cardiovasc Revasc Med; 2024 Oct; 67():77-83. PubMed ID: 38702260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.